Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biocon Limited

BIOCON
Current price
335.8 INR +1.95 INR (+0.58%)
Last closed 331.55 INR
ISIN INE376G01013
Sector Healthcare
Industry Biotechnology
Exchange National Stock Exchange of India
Capitalization 384 962 614 443 INR
Yield for 12 month +44.27 %
1Y
3Y
5Y
10Y
15Y
BIOCON
21.11.2021 - 28.11.2021

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India. Address: 20th KM Hosur Road, Bengaluru, India, 560100

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

27 962.48 INR

P/E ratio

26.7304

Dividend Yield

0.15 %

Current Year

+147 617 459 432 INR

Last Year

+111 787 784 752 INR

Current Quarter

+35 464 525 110 INR

Last Quarter

+34 343 065 864 INR

Current Year

+57 110 390 593 INR

Last Year

+75 141 775 658 INR

Current Quarter

+23 633 679 645 INR

Last Quarter

+11 219 595 217 INR

Key Figures BIOCON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 31 874 054 825 INR
Operating Margin TTM 7.4 %
PE Ratio 26.7304
Return On Assets TTM 1.77 %
PEG Ratio
Return On Equity TTM 7.31 %
Wall Street Target Price 27 962.48 INR
Revenue TTM 149 002 023 130 INR
Book Value 170.64 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3.7 %
Dividend Yield 0.15 %
Gross Profit TTM 54 678 394 543 INR
Earnings per share 12.02 INR
Diluted Eps TTM 12.02 INR
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 548.2 %
Profit Margin 9.66 %

Dividend Analytics BIOCON

Dividend growth over 5 years

200 %

Continuous growth

1 year

Payout Ratio 5 years average

18 %

Dividend History BIOCON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.5
Ex Dividend Date 05.07.2024
Forward Annual Dividend Yield 0.16 %
Last Split Factor 2:1
Payout Ratio 4.37 %
Last Split Date 12.06.2019
Dividend Date

Stock Valuation BIOCON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 26.7304
Forward PE
Enterprise Value Revenue 3.6368
Price Sales TTM 2.578
Enterprise Value EBITDA 10.4818
Price Book MRQ 1.833

Financials BIOCON

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIOCON

For 52 weeks

228.03 INR 395.96 INR
50 Day MA 351.42 INR
Shares Short Prior Month
200 Day MA 320.43 INR
Short Ratio
Shares Short
Short Percent